2012 annual financial data
BioCryst Pharmaceuticals 2012 Operating margin
Direct answer
Operating margin was -128.89%.
Operating income was -33,888,000 USD and net income was -39,081,000 USD.
Operating cash flow was -37,397,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,293,000 USD
- Operating income
- -33,888,000 USD
- Net income
- -39,081,000 USD
- Operating cash flow
- -37,397,000 USD